1. Home
  2. APGE vs MTRN Comparison

APGE vs MTRN Comparison

Compare APGE & MTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • MTRN
  • Stock Information
  • Founded
  • APGE 2022
  • MTRN 1931
  • Country
  • APGE United States
  • MTRN United States
  • Employees
  • APGE 196
  • MTRN N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • MTRN Industrial Specialties
  • Sector
  • APGE Health Care
  • MTRN Industrials
  • Exchange
  • APGE Nasdaq
  • MTRN Nasdaq
  • Market Cap
  • APGE 2.2B
  • MTRN 1.8B
  • IPO Year
  • APGE 2023
  • MTRN N/A
  • Fundamental
  • Price
  • APGE $37.61
  • MTRN $101.68
  • Analyst Decision
  • APGE Strong Buy
  • MTRN Strong Buy
  • Analyst Count
  • APGE 4
  • MTRN 2
  • Target Price
  • APGE $97.50
  • MTRN $116.00
  • AVG Volume (30 Days)
  • APGE 1.2M
  • MTRN 220.1K
  • Earning Date
  • APGE 08-11-2025
  • MTRN 07-30-2025
  • Dividend Yield
  • APGE N/A
  • MTRN 0.55%
  • EPS Growth
  • APGE N/A
  • MTRN N/A
  • EPS
  • APGE N/A
  • MTRN 0.78
  • Revenue
  • APGE N/A
  • MTRN $1,725,574,000.00
  • Revenue This Year
  • APGE N/A
  • MTRN $0.61
  • Revenue Next Year
  • APGE $743.14
  • MTRN $6.78
  • P/E Ratio
  • APGE N/A
  • MTRN $131.16
  • Revenue Growth
  • APGE N/A
  • MTRN 5.52
  • 52 Week Low
  • APGE $26.20
  • MTRN $69.10
  • 52 Week High
  • APGE $63.50
  • MTRN $123.21
  • Technical
  • Relative Strength Index (RSI)
  • APGE 42.46
  • MTRN 71.65
  • Support Level
  • APGE $37.05
  • MTRN $91.62
  • Resistance Level
  • APGE $42.29
  • MTRN $97.75
  • Average True Range (ATR)
  • APGE 1.78
  • MTRN 3.17
  • MACD
  • APGE -0.13
  • MTRN 0.63
  • Stochastic Oscillator
  • APGE 14.44
  • MTRN 90.52

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About MTRN Materion Corporation

Materion Corp specializes in the development of specialty engineered alloy systems, inorganic chemicals and powders, precious and non-precious metals, beryllium and beryllium composites, and precision filters and optical coatings. The company operates in four reportable segments: Performance Materials, Electronic Materials, Precision Optics, and Others. The majority of revenue is derived from Electronic Materials which produces chemicals, microelectronics packaging, precious metal, non-precious metal, and specialty metal products, including vapor deposition targets, frame lid assemblies, clad and precious metal pre-forms. The Performance Materials segment provides engineered solutions comprised of beryllium and non-beryllium-containing alloy systems and custom-engineered parts.

Share on Social Networks: